0001209191-18-010365.txt : 20180215
0001209191-18-010365.hdr.sgml : 20180215
20180215161239
ACCESSION NUMBER: 0001209191-18-010365
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180213
FILED AS OF DATE: 20180215
DATE AS OF CHANGE: 20180215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BALOUSEK JOHN
CENTRAL INDEX KEY: 0001168586
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33268
FILM NUMBER: 18617824
MAIL ADDRESS:
STREET 1: 303 PEACHTREE CENTER AVE
STREET 2: SUITE 500
CITY: ALTANTA
STATE: GA
ZIP: 30303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CENTRAL GARDEN & PET CO
CENTRAL INDEX KEY: 0000887733
STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MISCELLANEOUS NONDURABLE GOODS [5190]
IRS NUMBER: 680275553
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0926
BUSINESS ADDRESS:
STREET 1: 1340 TREAT BOULEVARD
STREET 2: SUITE 600
CITY: WALNUT CREEK
STATE: CA
ZIP: 94597
BUSINESS PHONE: 9259484000
MAIL ADDRESS:
STREET 1: 1340 TREAT BOULEVARD
STREET 2: SUITE 600
CITY: WALNUT CREEK
STATE: CA
ZIP: 94597
FORMER COMPANY:
FORMER CONFORMED NAME: CENTRAL GARDEN & PET COMPANY
DATE OF NAME CHANGE: 19941019
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-13
0
0000887733
CENTRAL GARDEN & PET CO
CENT
0001168586
BALOUSEK JOHN
C/O CENTRAL GARDEN & PET COMPANY
1340 TREAT BLVD, SUITE 600
WALNUT CREEK
CA
94597
1
0
0
0
Class A Common Stock
2018-02-13
4
A
0
542
0.00
A
6182
D
Class A Common Stock
1455
I
By Balousek Family L.P.
Common Stock
5160
I
By Balousek Family L.P.
Stock Option (Right to Buy)
36.94
2018-02-13
4
A
0
5415
0.00
A
2021-08-13
Class A Common Stock
5415
5415
D
Restricted stock award granted under the Company's Nonemployee Director Equity Incentive Plan, as amended
By Balousek Family L.P. Mr. Balousek is the general partner of Balousek Family L.P. Mr. Balousek disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Stock options granted under the Company's Nonemployee Director Equity Incentive Plan, as amended.
One-third of the total options granted will become exercisable at each of 6 months, 18 months and 30 months after February 13, 2018, the date of the grant.
/s/ John Balousek
2018-02-14